METASTATIC
Clinical trials for METASTATIC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC trials appear
Sign up with your email to follow new studies for METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new combination of two existing drugs, lorlatinib and ramucirumab, for people with advanced lung cancer that has a specific genetic change called ALK. The main goals are to find the safest dose of the drug combination and to see how well it works at contro…
Matched conditions: METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing a combination of three drugs (surufatinib, sintilimab, and capecitabine) for people with advanced small bowel or appendix cancer that has spread and worsened after at least one prior treatment. The main goals are to see if this combination is safe and if it …
Matched conditions: METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Radioactive ray of hope: first test of new drug for deadly eye cancer
Disease control Recruiting nowThis is the first-ever study in people of an experimental radioactive drug called 225Ac-MTI-201. It aims to find the safest dose for patients with metastatic uveal melanoma, a rare and aggressive eye cancer that has spread after other treatments failed. The study will also track …
Matched conditions: METASTATIC
Phase: PHASE1 • Sponsor: Modulation Therapeutics, Inc. • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC